Murat Albayrak

5PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 06, 2024
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis

Ünal Ataş, Ozan Salim, Utku Iltar

|Oct 25, 2023
Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study

Emine Merve Savaş, Seda Yılmaz, Ayşe Asena Başer Dikyar

|Dec 14, 2021
The outcome of COVID-19 in patients with hematological malignancy.

Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu

|Aug 23, 2021
Leukocytoclastic vasculitis due to ruxolitinib treatment: A rare adverse effect.

Mesut Tığlıoğlu, Pınar Tığlıoğlu, Abdulkerim Yıldız

|Jun 25, 2021
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Olga Meltem Akay, Murat Ozbalak, Mustafa Pehlivan

Pageof 1

Frequent Collaborators

2 joint publications

Meltem Aylı

2 joint publications

Merih Reis Aras

2 joint publications

Pınar Tığlıoğlu

2 joint publications

Ozgur Mehtap